Understanding Agentic AI in Clinical Development Read more 

GSK axes key cough drug candidate after phase 3 data end blockbuster hopes Read more 

Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal Read more 

Go to Top